Australia markets closed

Corcept Therapeutics Incorporated (CORT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
40.92-1.35 (-3.19%)
At close: 04:00PM EDT
41.73 +0.81 (+1.98%)
Pre-market: 08:18AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 4.28B
Enterprise value 3.81B
Trailing P/E 36.21
Forward P/E 22.68
PEG ratio (5-yr expected) N/A
Price/sales (ttm)7.96
Price/book (mrq)7.17
Enterprise value/revenue 6.69
Enterprise value/EBITDA 29.55

Trading information

Stock price history

Beta (5Y monthly) 0.45
52-week change 329.33%
S&P500 52-week change 332.26%
52-week high 343.74
52-week low 320.84
50-day moving average 335.08
200-day moving average 328.51

Share statistics

Avg vol (3-month) 3863.68k
Avg vol (10-day) 3900.05k
Shares outstanding 5104.49M
Implied shares outstanding 6107.94M
Float 885.37M
% held by insiders 111.55%
% held by institutions 187.39%
Shares short (30 Aug 2024) 422.09M
Short ratio (30 Aug 2024) 426.86
Short % of float (30 Aug 2024) 429.71%
Short % of shares outstanding (30 Aug 2024) 421.14%
Shares short (prior month 31 July 2024) 422.26M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 June 2024

Profitability

Profit margin 22.12%
Operating margin (ttm)22.03%

Management effectiveness

Return on assets (ttm)12.91%
Return on equity (ttm)24.75%

Income statement

Revenue (ttm)569.61M
Revenue per share (ttm)5.55
Quarterly revenue growth (yoy)39.10%
Gross profit (ttm)N/A
EBITDA 128.58M
Net income avi to common (ttm)124.96M
Diluted EPS (ttm)1.13
Quarterly earnings growth (yoy)28.90%

Balance sheet

Total cash (mrq)473.16M
Total cash per share (mrq)4.53
Total debt (mrq)5.67M
Total debt/equity (mrq)0.95%
Current ratio (mrq)5.57
Book value per share (mrq)5.71

Cash flow statement

Operating cash flow (ttm)123.73M
Levered free cash flow (ttm)124.42M